Could a finger prick replace needles for cancer drug monitoring?
NCT ID NCT06545292
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study is testing whether a simple finger-prick blood sample (dried blood spot) can accurately measure levels of certain cancer drugs in the body. Researchers will compare results from the finger-prick method with standard blood draws in 360 adults taking oral or infused cancer medications. If the finger-prick method works well, it could allow patients to monitor their drug levels from home, making treatment more convenient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dried blood spot microsampling (diagnostic test)
- What this could lead to
- If successful, this could allow cancer patients to monitor their medication levels from home with a simple finger prick, reducing hospital visits.
- What could go wrong
- This is an early validation study, not a treatment trial. The finger-prick method may not match standard blood draws closely enough, and home sampling may be impractical for some patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG MONITORING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Leiden University Medical Center
RECRUITINGLeiden, South Holland, 2333ZA, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.